{"id":"https://openalex.org/W2071476015","doi":"https://doi.org/10.1016/j.euroneuro.2015.01.014","title":"Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin\u2013dopamine activity modulator: A role for serotonin 5-HT1A and 5-HT2A receptors","display_name":"Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin\u2013dopamine activity modulator: A role for serotonin 5-HT1A and 5-HT2A receptors","alternate_titles":[],"publication_year":2015,"publication_date":"2015-02-07","ids":{"openalex":"https://openalex.org/W2071476015","doi":"https://doi.org/10.1016/j.euroneuro.2015.01.014","mag":"2071476015","pmid":"https://pubmed.ncbi.nlm.nih.gov/25687838"},"language":"en","primary_location":{"id":"doi:10.1016/j.euroneuro.2015.01.014","doi":"https://doi.org/10.1016/j.euroneuro.2015.01.014","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2015.01.014","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0924977X15000152/pdf","source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2071476015"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0924977X15000152/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027739931","display_name":"Tamaki Ishima","orcid":"https://orcid.org/0009-0002-2309-265X","observed_orcids":["https://orcid.org/0009-0002-2309-265X"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4210162351","display_name":"Center for Forensic Mental Health, Chiba University","ror":"https://ror.org/05b0gpy83","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tamaki Ishima","raw_affiliation_strings":["Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087792958","display_name":"Takashi Futamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Futamura","raw_affiliation_strings":["Qs\u05f3 Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Qs\u05f3 Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035289960","display_name":"Yuta Ohgi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4210162351","display_name":"Center for Forensic Mental Health, Chiba University","ror":"https://ror.org/05b0gpy83","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuta Ohgi","raw_affiliation_strings":["Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan; Qs\u05f3 Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan","Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan","Qs' Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan; Qs\u05f3 Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]},{"raw_affiliation_string":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]},{"raw_affiliation_string":"Qs' Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Noriko Yoshimi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4210162351","display_name":"Center for Forensic Mental Health, Chiba University","ror":"https://ror.org/05b0gpy83","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Yoshimi","raw_affiliation_strings":["Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan; Qs\u05f3 Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan","Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan","Qs' Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan; Qs\u05f3 Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]},{"raw_affiliation_string":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]},{"raw_affiliation_string":"Qs' Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062112121","display_name":"Tetsuro Kikuchi","orcid":"https://orcid.org/0000-0002-3902-7302","observed_orcids":["https://orcid.org/0000-0002-3902-7302"]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tetsuro Kikuchi","raw_affiliation_strings":["Qs\u05f3 Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Qs\u05f3 Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032453300","display_name":"Kenji Hashimoto","orcid":"https://orcid.org/0000-0002-8892-0439","observed_orcids":["https://orcid.org/0000-0002-8892-0439"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4210162351","display_name":"Center for Forensic Mental Health, Chiba University","ror":"https://ror.org/05b0gpy83","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kenji Hashimoto","raw_affiliation_strings":["Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan. Electronic address: hashimoto@faculty.chiba-u.jp","Division of Clinical Neuroscience Chiba University Center for Forensic Mental Health Chiba Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan. Electronic address: hashimoto@faculty.chiba-u.jp","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]},{"raw_affiliation_string":"Division of Clinical Neuroscience Chiba University Center for Forensic Mental Health Chiba Japan","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5032453300"],"corresponding_institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":3.8077,"has_fulltext":true,"cited_by_count":43,"citation_normalized_percentile":{"value":0.93178577,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"25","issue":"4","first_page":"505","last_page":"511"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.5156000256538391,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.5156000256538391,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.35670000314712524,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.06509999930858612,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brexpiprazole","display_name":"brexpiprazole","score":1.0},{"id":"https://openalex.org/keywords/neurite-outgrowth","display_name":"neurite outgrowth","score":0.9940000176429749},{"id":"https://openalex.org/keywords/5-ht1a-receptor","display_name":"5-HT1A receptor","score":0.8849999904632568},{"id":"https://openalex.org/keywords/5-ht2a-receptor","display_name":"5-HT2A receptor","score":1.0},{"id":"https://openalex.org/keywords/nerve-growth-factor","display_name":"nerve growth factor","score":0.8650000095367432},{"id":"https://openalex.org/keywords/pc12-cells","display_name":"PC12 cells","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ip3-receptor","display_name":"IP3 receptor","score":0.7210000157356262},{"id":"https://openalex.org/keywords/calcium-signaling","display_name":"calcium signaling","score":0.9909999966621399},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.7730000019073486},{"id":"https://openalex.org/keywords/way-100635","display_name":"WAY-100635","score":0.8600000143051147},{"id":"https://openalex.org/keywords/m100907","display_name":"M100907","score":0.9449999928474426},{"id":"https://openalex.org/keywords/xestospongin-c","display_name":"xestospongin C","score":0.8930000066757202},{"id":"https://openalex.org/keywords/2-apb","display_name":"2-APB","score":0.9169999957084656},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.8679999709129333}],"concepts":[{"id":"https://openalex.org/C113246987","wikidata":"https://www.wikidata.org/wiki/Q1534415","display_name":"Neurite","level":3,"score":0.7076369524002075},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.6530357003211975},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.638353705406189},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5514751076698303},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.49753859639167786},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.4766312837600708},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45949414372444153},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.45686787366867065},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.4327833652496338},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.4199703633785248},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.37088337540626526},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.25679832696914673},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18453574180603027},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10210290551185608},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06988254189491272}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001896","descriptor_name":"Boron Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005464","descriptor_name":"Fluorobenzenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010080","descriptor_name":"Oxazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016501","descriptor_name":"Neurites","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016716","descriptor_name":"PC12 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018490","descriptor_name":"Serotonin Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018841","descriptor_name":"HSP90 Heat-Shock Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020932","descriptor_name":"Nerve Growth Factor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044282","descriptor_name":"Receptor, Serotonin, 5-HT1A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D044402","descriptor_name":"Receptor, Serotonin, 5-HT2A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D047028","descriptor_name":"Macrocyclic Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053496","descriptor_name":"Inositol 1,4,5-Trisphosphate Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D053496","descriptor_name":"Inositol 1,4,5-Trisphosphate Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.euroneuro.2015.01.014","doi":"https://doi.org/10.1016/j.euroneuro.2015.01.014","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2015.01.014","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0924977X15000152/pdf","source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmid:25687838","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25687838","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.euroneuro.2015.01.014","doi":"https://doi.org/10.1016/j.euroneuro.2015.01.014","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2015.01.014","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0924977X15000152/pdf","source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2071476015.pdf","grobid_xml":"https://content.openalex.org/works/W2071476015.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1966901093","https://openalex.org/W1970705129","https://openalex.org/W1974342767","https://openalex.org/W1980166477","https://openalex.org/W1994450781","https://openalex.org/W1999779256","https://openalex.org/W2004310280","https://openalex.org/W2004450011","https://openalex.org/W2004581580","https://openalex.org/W2004923706","https://openalex.org/W2006080570","https://openalex.org/W2009472577","https://openalex.org/W2009825154","https://openalex.org/W2017946241","https://openalex.org/W2025474034","https://openalex.org/W2032770343","https://openalex.org/W2037081441","https://openalex.org/W2041806676","https://openalex.org/W2042809289","https://openalex.org/W2048382065","https://openalex.org/W2064065127","https://openalex.org/W2065448268","https://openalex.org/W2067025220","https://openalex.org/W2092109656","https://openalex.org/W2092572691","https://openalex.org/W2113902650","https://openalex.org/W2128717592","https://openalex.org/W2142688346","https://openalex.org/W2151839057","https://openalex.org/W2153784874","https://openalex.org/W2154299176","https://openalex.org/W2319946110","https://openalex.org/W2770977268"],"related_works":["https://openalex.org/W2041180433","https://openalex.org/W2009825154","https://openalex.org/W2047830486","https://openalex.org/W2152358682","https://openalex.org/W2151839057","https://openalex.org/W2041806676","https://openalex.org/W1967743869","https://openalex.org/W4249359167","https://openalex.org/W2570108224","https://openalex.org/W2180613923"],"abstract_inverted_index":{"Brexpiprazole,":[0],"a":[1,32,91],"novel":[2],"atypical":[3],"antipsychotic":[4,55],"drug,":[5],"is":[6,27,166],"currently":[7],"being":[8],"tested":[9],"in":[10,72,87,90],"clinical":[11],"trials":[12],"for":[13],"treatment":[14],"of":[15,34,107,148,157],"psychiatric":[16],"disorders,":[17],"such":[18],"as":[19],"schizophrenia":[20],"and":[21,41,45,141,170,173],"major":[22],"depressive":[23],"disorder.":[24],"The":[25,95],"drug":[26],"known":[28],"to":[29,103],"act":[30,57],"through":[31,168],"combination":[33],"partial":[35],"agonistic":[36],"activity":[37,47],"at":[38,48],"5-hydroxytryptamine":[39],"(5-HT)1A,":[40],"dopamine":[42,115],"D2":[43,116],"receptors,":[44,152,172],"antagonistic":[46],"5-HT2A":[49,123,171],"receptors.":[50,179],"Accumulating":[51],"evidence":[52],"suggests":[53],"that":[54,77,162],"drugs":[56],"by":[58],"promoting":[59],"neurite":[60,70,85,110,136,164],"outgrowth.":[61,137],"In":[62],"this":[63],"study,":[64],"we":[65],"examined":[66],"whether":[67],"brexpiprazole":[68,78,108],"affected":[69],"outgrowth":[71,86,165],"cell":[73],"culture.":[74],"We":[75],"found":[76],"significantly":[79,133,153],"potentiated":[80,134],"nerve":[81],"growth":[82],"factor":[83],"(NGF)-induced":[84],"PC12":[88],"cells,":[89],"concentration":[92],"dependent":[93],"manner.":[94],"selective":[96,114,122],"5-HT1A":[97,169],"receptor":[98,117,124,131],"antagonist,":[99,118],"WAY-100,635,":[100],"was":[101],"able":[102],"block":[104],"the":[105,113,121,155],"effects":[106,156],"on":[109],"outgrowth,":[111],"unlike":[112],"raclopride.":[119],"Furthermore,":[120],"antagonist":[125],"M100907,":[126],"but":[127],"not":[128],"DOI":[129],"(5-HT2A":[130],"agonist),":[132],"NGF-induced":[135],"Moreover,":[138],"xestospongin":[139],"C":[140],"2-aminoethoxydiphenyl":[142],"borate":[143],"(2-APB),":[144],"both":[145],"specific":[146],"inhibitors":[147],"inositol":[149],"1,4,5-triphosphate":[150],"(IP3)":[151],"blocked":[154],"brexpiprazole.":[158],"These":[159],"findings":[160],"suggest":[161],"brexpiprazole-induced":[163],"mediated":[167],"subsequent":[174],"Ca(2+)":[175],"signaling":[176],"via":[177],"IP3":[178]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2071476015","counts_by_year":[{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
